- Details
- Description
-
Packaging Size60t/bottle
-
Strength80mg
-
CompositonLazertinib
-
TreatmentEGFR+ Non Small Cell Lung Cancer
-
FormTablets
-
BrandLuciLazer
-
Quantity Unit80mg*60t/Box
-
ManufacturerLucius Pharmaceuticals (Lao) Co.,Ltd
Lazertinib is a potent irreversible, brain-penetrant, third-generation EGFR TKI exhibiting high selectivity for both activating and T790M EGFR resistance mutations while reducing the common drug-related treatment-emergent adverse events (TEAEs) (such as rash and diarrhea) associated with inhibition of wild-type (WT) EGFR activity .
Lazertinib comes as a tablet to take by mouth. It is usually taken with or without food once a day. Take lazertinib at around the same time every day. On the days that your receive amivantamab-vmjw injection, take lazertinib at any time before you receive the injection. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take lazertinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Swallow the tablets whole; do not split, chew, or crush them.
If you vomit after taking lazertinib, do not take another dose. Continue your regular dosing schedule.
Your doctor may need to temporarily or permanently stop your treatment or decrease your dose if you experience certain side effects. Be sure to talk to your doctor about how you are feeling during your treatment with lazertinib.
The length of your treatment depends on how well you respond to the medication and the side effects you experience. Continue to take lazertinib even if you feel well. Do not stop taking lazertinib without talking to your doctor.
Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.
